JP2017527268A5 - - Google Patents

Download PDF

Info

Publication number
JP2017527268A5
JP2017527268A5 JP2017502246A JP2017502246A JP2017527268A5 JP 2017527268 A5 JP2017527268 A5 JP 2017527268A5 JP 2017502246 A JP2017502246 A JP 2017502246A JP 2017502246 A JP2017502246 A JP 2017502246A JP 2017527268 A5 JP2017527268 A5 JP 2017527268A5
Authority
JP
Japan
Prior art keywords
sequence
monoclonal antibody
seq
complementarity determining
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017502246A
Other languages
English (en)
Japanese (ja)
Other versions
JP6495434B2 (ja
JP2017527268A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/040304 external-priority patent/WO2016010978A1/en
Publication of JP2017527268A publication Critical patent/JP2017527268A/ja
Publication of JP2017527268A5 publication Critical patent/JP2017527268A5/ja
Application granted granted Critical
Publication of JP6495434B2 publication Critical patent/JP6495434B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017502246A 2014-07-14 2015-07-14 サーファクタントタンパク質a受容体を標的とする組成物及び方法 Active JP6495434B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462024314P 2014-07-14 2014-07-14
US62/024,314 2014-07-14
US201562121830P 2015-02-27 2015-02-27
US62/121,830 2015-02-27
PCT/US2015/040304 WO2016010978A1 (en) 2014-07-14 2015-07-14 Compositions and methods for targeting of the surfactant protein a receptor

Publications (3)

Publication Number Publication Date
JP2017527268A JP2017527268A (ja) 2017-09-21
JP2017527268A5 true JP2017527268A5 (https=) 2018-04-19
JP6495434B2 JP6495434B2 (ja) 2019-04-03

Family

ID=55078969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017502246A Active JP6495434B2 (ja) 2014-07-14 2015-07-14 サーファクタントタンパク質a受容体を標的とする組成物及び方法

Country Status (8)

Country Link
US (1) US10077309B2 (https=)
EP (2) EP3733700A1 (https=)
JP (1) JP6495434B2 (https=)
CN (1) CN106604931B (https=)
AU (2) AU2015289831B2 (https=)
CA (2) CA3225495A1 (https=)
ES (1) ES2869909T3 (https=)
WO (1) WO2016010978A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112442126B (zh) * 2019-09-04 2022-07-29 杭州济元基因科技有限公司 一种抗人cs1抗原的单克隆抗体及其car-t细胞
EP4000597A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
CN116217718B (zh) * 2022-11-21 2023-08-25 浙江洪晟生物科技股份有限公司 一种猪丹毒抗体检测试剂盒及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE921342A1 (en) * 1991-04-26 1992-11-04 Surface Active Ltd Novel antibodies, and methods for their use
EP1649038B1 (en) 2003-06-26 2014-07-02 Litron Laboratories Ltd. Method for the enumeration of micronucleated erythrocyte populations while distinguishing platelets and/or platelet-associated aggregates
US8691730B2 (en) * 2007-09-14 2014-04-08 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8748113B2 (en) 2007-11-15 2014-06-10 The Johns Hopkins University Methods for detecting and monitoring circulating cancer stem cells
WO2010010467A2 (en) * 2008-07-25 2010-01-28 Institute For Research In Biomedicine Neutralizing anti-influenza a virus antibodies and uses thereof
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
CN104936977B (zh) 2012-10-24 2019-10-08 开普敦大学 微管修饰化合物

Similar Documents

Publication Publication Date Title
ES2662519T3 (es) Anticuerpos neutralizantes contra el virus de la gripe A y usos de estos
PE20181054A1 (es) Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion
PE20180480A1 (es) Anticuerpos de factor xi y metodos de uso
RU2014101707A (ru) АНТИ-Axl АНТИТЕЛА И ИХ ПРИМЕНЕНИЕ
JP2017149720A5 (https=)
RU2018106364A (ru) Антитела против рецептора tfr и их применение при лечении пролиферативных и воспалительных расстройств
RU2016107814A (ru) Новое антитело к tslp-рецептору человека
RU2017115315A (ru) Антитела к рецептору глюкокортикоид-индуцированного фактора некроза опухоли (gitr) и способы их применения
JP2011157378A5 (https=)
AR105026A1 (es) ANTICUERPOS MADURADOS POR AFINIDAD Y HUMANIZADOS PARA FcRH5 Y MÉTODOS PARA SU USO
JP2014111644A5 (https=)
PE20181270A1 (es) Anticuerpo que neutraliza el virus respiratorio sincitial humano
JP2010513228A5 (https=)
HRP20200034T1 (hr) Monoklonska protutijela protiv čimbenika rasta i diferencijacije 15 (gdf-15), te njihova upotreba u liječenju kaheksije uzrokovane rakom i raka
WO2017075432A3 (en) Anti-siglec-9 antibodies and methods of use thereof
PE20190398A1 (es) Anticuerpos nuevos que se unen especificamente a los epitopos del virus del zika y usos de los mismos
JP2017518260A5 (https=)
FI3683235T3 (fi) Anti-IL-33-vasta-aineita ja niiden käyttöjä
FI3334763T3 (fi) Uusia pd-l1-vasta-aineita
EA201790342A1 (ru) Антитела к trem2 и способы их применения
EA201792221A1 (ru) Антитела против сортилина и способы их применения
JP2016526904A5 (https=)
AR101875A1 (es) Proteína de unión a antígenos, bi-específicos del receptor anti-cgrp / receptor pac1 y usos de las mismas
RU2018133708A (ru) Антитела, обладающие специфичностью к btla, и их использование
ES2776179T3 (es) Anticuerpos dirigidos contra determinantes de la superficie de S. aureus